A detailed history of Carr Financial Group Corp transactions in Amgen Inc stock. As of the latest transaction made, Carr Financial Group Corp holds 3,108 shares of AMGN stock, worth $1 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,108
Previous 3,090 0.58%
Holding current value
$1 Million
Previous $965 Million 3.73%
% of portfolio
0.29%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$309.38 - $337.38 $5,568 - $6,072
18 Added 0.58%
3,108 $1 Billion
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $70,679 - $85,894
269 Added 9.54%
3,090 $965 Million
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $6,122 - $7,600
-28 Reduced 0.98%
2,821 $761 Million
Q2 2023

Jul 14, 2023

BUY
$214.27 - $253.37 $4,071 - $4,814
19 Added 0.67%
2,849 $633 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $648,154 - $823,558
2,830 New
2,830 $743 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.